Published in Scand J Urol Nephrol on January 01, 1979
Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet (1978) 3.74
Abnormal diurnal rhythm of urine output following renal transplantation: the impact of blood pressure and diuretics. Transplant Proc (2010) 1.45
Validity of D-dimer tests in the diagnosis of deep vein thrombosis: a prospective comparative study of three quantitative assays. J Intern Med (2002) 1.42
Complement-mediated reactions to diazepam with Cremophor as solvent (Stesolid MR). Br J Anaesth (1980) 1.08
On the inhibitory effect of albumin on platelet aggregation. Thromb Res (1980) 1.06
Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells. Br J Pharmacol (2011) 1.01
Catalytic Enantioselective Addition of Nitro Compounds to Imines-A Simple Approach for the Synthesis of Optically Active β-Nitro-α-Amino Esters. Angew Chem Int Ed Engl (2001) 0.95
The effect of prednisone on platelet function tests. Scand J Haematol (1982) 0.94
A novel catalytic and highly enantioselective approach for the synthesis of optically active carbohydrate derivatives. J Org Chem (2000) 0.92
Acetylsalicylic acid, bleeding time and age. Thromb Res (1980) 0.91
Nocturnal polyuria in monosymptomatic nocturnal enuresis refractory to desmopressin treatment. Am J Physiol Renal Physiol (2006) 0.90
Antagonist capacities of nifedipine, captopril, phenoxybenzamine, prostacyclin and indomethacin on cyclosporin A induced impairment of rat renal function. Eur J Clin Invest (1986) 0.89
Catalytic Asymmetric Direct Mannich Reactions of Carbonyl Compounds with α-Imino Esters. Angew Chem Int Ed Engl (2001) 0.88
Platelets and atherosclerosis. A review on the role of platelets in atherosclerosis with special reference to the role of polyunsaturated 20 carbon fatty acids. Dan Med Bull (1980) 0.87
Marine oils and thrombogenesis. Prog Lipid Res (1982) 0.87
Familial deficiency of prostacyclin production stimulating factor in the hemolytic uremic syndrome of childhood. Thromb Res (1981) 0.86
Familial functional antithrombin III deficiency. Scand J Haematol (1980) 0.86
Catalyhtic asymmetric Henry reactions--a simple approach to optically active beta-nitro alpha-hydroxy esters. Chem Commun (Camb) (2001) 0.84
Asymmetric catalysis of 1,3-dipolar cycloaddition reactions--the concepts of activation and induction of asymmetry. Sci Prog (1999) 0.82
Recurrent thrombosis in a patient with factor XII deficiency. Acta Haematol (1980) 0.82
Hydrocortisone inhibits platelet prostaglandin and endothelial prostacyclin production. Pharmacol Res Commun (1981) 0.82
Calcineurin activity in tacrolimus-treated renal transplant patients early after and 5 years after transplantation. Transplant Proc (2006) 0.81
Comparison of the pharmacokinetics of tacrolimus and cyclosporine at equivalent molecular doses. Transplant Proc (2003) 0.81
Stability of prostacyclin in plasma. Lancet (1979) 0.80
Alterations in calcineurin phosphatase activity in tacrolimus-treated renal transplant patients. Transplant Proc (2002) 0.80
Platelet aggregation is not essential for xenograft rejection. Thromb Res (1986) 0.80
Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients. Transplant Proc (2005) 0.80
Amyl nitrite and Kaposi's sarcoma in homosexual men. N Engl J Med (1982) 0.80
24-h monitoring of calcineurin phosphatase activity in healthy subjects. Scand J Immunol (2005) 0.79
Gene expression analysis of calcineurin isoforms in T-lymphocytes--a method applied on kidney-transplant recipients. Transpl Immunol (2010) 0.79
Flush perfusion of rabbit kidneys with autogeneic, allogeneic and xenogeneic blood. Scand J Urol Nephrol (1991) 0.79
Alterations in plasma antithrombin III following total hip replacement and elective cholecystectomy. Scand J Haematol (1980) 0.79
Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation. Pharmacol Res Commun (1979) 0.79
Antithrombin III and the nephrotic syndrome. Scand J Haematol (1979) 0.79
The complement system in uremia. Scand J Urol Nephrol (1980) 0.78
Ketoconazole and cyclosporine A: combined effects on rat renal function and on serum and tissue cyclosporine A concentration. Clin Nephrol (1986) 0.78
Aspirin and bleeding-time: dependency of age. Lancet (1979) 0.77
Xenoperfusion of rabbit kidney and the impact of BN 52021: a specific antagonist of platelet-activating factor. Transplant Proc (1990) 0.77
A biphasic effect of prostacyclin (PGI2) on platelet aggregation. Thromb Res (1980) 0.77
Hemostatic factors and renin in Greenland Eskimos on a high eicosapentaenoic acid intake. Results of the Fifth UmanaK Expedition. Acta Med Scand (1986) 0.77
Heparin like activity of albumin. Thromb Res (1979) 0.77
The effect of arachidonic- and eicosapentaenoic acid on the synthesis of prostacyclin-like material in human umbilical vasculature. Artery (1980) 0.77
EBV-induced post-transplant lymphoproliferative disorder (PTLD). Transplant Proc (1995) 0.76
Development of anti-OKT3 antibodies after OKT3 treatment. Scand J Urol Nephrol (1996) 0.76
Charcoal haemoperfusion and antidepressant overdose. Lancet (1978) 0.76
Heparin-free hypothermal hemodialysis at 20 degrees C improves biocompatibility. Blood Purif (1997) 0.76
[Hemoperfusion in deliberate drug poisoning. Review and 2 case reports]. Ugeskr Laeger (1978) 0.76
Human umbilical blood vessel converts all cis-5, 8, 11, 14, 17 eicosapentaenoic acid to prostaglandin I3. Prostaglandins (1981) 0.76
The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion: a randomized crossover trial in uraemic patients. Diabet Med (2012) 0.76
Severe neutropenia after renal transplantation and its reversal with granulocyte colony-stimulating factor. Transplant Proc (1994) 0.75
Islet and kidney transplantation using ATG and cyclosporin monotherapy and a central facility for islet isolation and purification. Transplant Proc (1995) 0.75
Activation of fibrinolysis during xenoperfusion. Thromb Res (1987) 0.75
Orthoclone OKT3 as first-line therapy in acute renal allograft rejection. Transplant Proc (1990) 0.75
Acetylsalicylic acid and bleeding time in juvenile diabetes mellitus. Thromb Res (1981) 0.75
Detection of inhibitory anti-OKT3 antibodies in renal transplant patients. Transplant Proc (1994) 0.75
On the role of platelets and leucocyte in renal xenoperfusion. Acta Pathol Microbiol Immunol Scand A (1986) 0.75
[Legionnaires' disease in Denmark imported from Italy]. Ugeskr Laeger (1979) 0.75
Platelets and platelet function in patients with chronic uremia on maintenance hemodialysis. Nephron (1979) 0.75
Analysis of the inflammatory leucocyte mobilization in 838 fine needle aspiration biopsies in non-rejecting (day 1-90) kidney grafts and 465 biopsies in grafts before, during and after acute cellular rejection. Transpl Immunol (1994) 0.75
[Nosocomial Legionella pneumophila infection in a nephrology department]. Ugeskr Laeger (1995) 0.75
Antithrombin III. A review. Dan Med Bull (1983) 0.75
Cyclosporine monotherapy in children: long-term effect. Transplant Proc (1994) 0.75
Platelet dysfunction in patients with vitamin B12 deficiency. Acta Haematol (1979) 0.75
Pinacidil--effects on function and perfusion of normal kidneys and renal xenografts. J Hypertens (1983) 0.75
First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization. Transplant Proc (1990) 0.75
[Antithrombin III deficiency in the nephrotic syndrome. Threatened thrombosis treated with fresh plasma]. Ugeskr Laeger (1984) 0.75
Legionnaires' disease imported to Denmark from Italy. Scand J Infect Dis (1981) 0.75
Effect of etomidate and metronidazole on platelet aggregation. Br J Anaesth (1988) 0.75
The reaction of N-nitroso compounds with 2,4-bis (4-methoxyphenyl)-1,3,2,4-dithiadiphosphetane-2,4-disulfide. New aspects of the destruction of the N-nitroso function. IARC Sci Publ (1980) 0.75
Does the method of heparinisation influence the biocompatibility of dialysis membranes? Nephrol Dial Transplant (1991) 0.75
[A longitudinal study of the nutritional status of chronic dialysis patients]. Ugeskr Laeger (1990) 0.75
Optimization of cyclosporine monotherapy--long-term graft function. Transplant Proc (1994) 0.75
Chronic rejection in kidney transplant patients receiving cytomegalovirus prophylaxis with acyclovir. Transplant Proc (1995) 0.75
C3 polymorphism in patients with chronic uremia. Hum Hered (1980) 0.75
Hydrocortisone, platelet aggregation and platelet prostaglandin metabolism. Scand J Haematol (1980) 0.75
Prostacyclin and haemolytic, thrombocytopenic microangiopathy. Lancet (1981) 0.75
[A case of factor XI deficiency--hemophilia C]. Ugeskr Laeger (1979) 0.75
Platelets and renal disease. A review. Dan Med Bull (1981) 0.75
The survival of pig to rabbit renal xenografts during inhibition of thromboxane synthesis. Thromb Res (1983) 0.75
Xeno- and auto-perfusion of rabbit kidney. Machine perfusion with blood at 37 degrees C. Acta Pathol Microbiol Immunol Scand A (1985) 0.75
Effect of glucocorticosteroids on some coagulation tests. Acta Haematol (1982) 0.75
Antithrombin III and dietary intake of polyunsaturated fatty acids. Scand J Clin Lab Invest (1982) 0.75
The destruction of N-nitrosamides with 2,4-bis(4-methoxyphenyl)-1,3,2,4-dithiodiphosphetane-2,4-disulfide. Attempts to nitrosate thioamides. IARC Sci Publ (1982) 0.75
[Hemolytic uremic syndrome]. Ugeskr Laeger (1978) 0.75
[Acute renal failure caused by paracetamol poisoning]. Ugeskr Laeger (1993) 0.75
Platelets and atherosclerosis. Adv Nutr Res (1983) 0.75
[Afibrinogenemia and the Bernard-Soulier syndrome]. Ugeskr Laeger (1977) 0.75
Xenoperfusion of pig kidney with human AB or O whole blood. Transplant Proc (1990) 0.75
[Nitrosation reagents (e.g. amyl nitrite) as possible cause of Kaposi's sarcoma in homosexual men]. Ugeskr Laeger (1982) 0.75
[Legionnaires' disease in Denmark]. Ugeskr Laeger (1979) 0.75